Member Info for Sangijuelas1

So who else do you think is selling? Every day since the day of Forte's crash there has been significant selling over and above the auto trades which he been going on for well over a year.

Oliveira lost about $50m and he had 14m shares in 4D plus his stake in LBPS.

Why are you so obsessed with the short sellers? There's nothing you can do about it

Either way, clearly some decent buying today. Wonder why today as opposed to last week?

FFS there's more than one thing going on.

Oliveira sells a big chunk, someone else is buying, the algos short it, then they buy some to take profit from earlier trades, PI traders buy the rise then dump when it hits their loss limit

The sells are Oliveira. He has been selling for over 3 weeks. That's why we are where we are with the price.

There have been some significant sells 2x47k and 1 for 65k that I have seen as well as plenty of others

It's just you never talk about anything else. Day in day out. People don't understand the potential of the company because they are racking their brains to interpret the trades which is a bit like reading tea leaves.

All the talk about the price and the trades means you don't get to see the wood for the trees

How much did you miss out on with Ocado again?

I am sure that those who bought your shares will truly live to regret it

Market reassessing the old Woodford stocks given the astronomical valuation given to Oxford Nanopore

Lots of data due

Tweet this morning hinting at doctors and patients liking live biotherapeutics, which is suggestive of seeking approval

End of the Oliveira Firesale

They said by the end of the year. They want the release to be comprehensive and to include tum biomarker analysis.

Shorts will need to close. They were selling all the way down.

Big buyers waiting for end of Oliveira firesale

I honestly think early approval of 0518 is on the cards

Don't be a fool Researcher1. It will be Ocado all over again.

How much did you miss out on there?

Asthma results
Blautix plans
Pancreatic cancer readout
0518 interim data

Why is this mornings tweet highlighting the point that patients and doctors will like the sound of Live Biotherapeutics due to the absence of side effects.?

Market will be looking amongst the old Woodford stocks for the next Oxford Nanopore which now has market cap £5bn

I don't know what placebo. Just says placebo on clinicaltrials.gov

Come on people, they are tipping us off here

In the Blautix trial the placebo effect was significantly higher in the smaller group of UK patients whereas it was minimal in the larger group of US patients.

"If you can bring a drug that has no side effects or tox issues, that really resonates with clinicians, and obviously with patients"

Sounds like they are emphasising marketing potential pre approval

https://mobile.twitter.com/4dpharmaplc/status/1444942211658002434